T-cell lymphomas account for 10-15 % of all adult non-Hodgkin lymphomas. Progress in understanding the biology of these lymphomas leads to improvement in their molecular classifications. However, the management of patients with T-cell lymphoma remains challenging, as these patients continue to have worse treatment outcome compared with B-cell lymphomas. In this chapter, we review the recent advances in T-cell lymphoma biology and emerging therapeutic strategies.
- Hematopoietic cell transplantation
- Non-Hodgkin lymphoma
- T-cell lymphoma
ASJC Scopus subject areas